source
- Roche scraps two Ionis-partnered Huntington’s drugsThe Swiss pharmaceutical giant told patient groups tominersen didn't delay disease progression in one trial, while a study of a second drug was scrapped because of a safety signal in animal testing.
- Mid-year roundup highlights top health-tech trends in 2026The editorial team notes that the first half of 2026 has been unusually active for health technology. Five major developments have been identified as the most significant so far. One clear theme i…